{"id":"vitamin-k-2","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vitamin K2 (menaquinone) is an essential cofactor for the enzyme gamma-glutamyl carboxylase, which catalyzes the post-translational carboxylation of glutamic acid residues in bone proteins (osteocalcin, matrix Gla protein) and vascular proteins. This carboxylation is required for these proteins to bind calcium and exert their physiological effects on bone metabolism and vascular calcification prevention.","oneSentence":"Vitamin K2 acts as a cofactor for gamma-carboxylation of bone and vascular proteins, enabling their biological activity in bone mineralization and cardiovascular health.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:15:36.433Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bone health and osteoporosis prevention"},{"name":"Cardiovascular health and vascular calcification prevention"}]},"trialDetails":[{"nctId":"NCT05900388","phase":"","title":"A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)","status":"NOT_YET_RECRUITING","sponsor":"Bayer","startDate":"2026-09-01","conditions":"Venous Thromboembolism, Children Under 2 Years","enrollment":850},{"nctId":"NCT07471139","phase":"PHASE3","title":"SWITCH: Apixaban vs Vitamin K in HM3","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-06","conditions":"LVAD (Left Ventricular Assist Device) Thrombosis, Heart Failure, Bleeding","enrollment":460},{"nctId":"NCT02592317","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aragon Pharmaceuticals, Inc.","startDate":"2016-02-12","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":23},{"nctId":"NCT04618913","phase":"","title":"Anticoagulation in Patients With Venous Thromboembolism and Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2020-12-14","conditions":"Neoplasms, Embolism","enrollment":1},{"nctId":"NCT05038228","phase":"","title":"High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2022-08-01","conditions":"Atrial Fibrillation","enrollment":1},{"nctId":"NCT06817512","phase":"NA","title":"Ischemic Stroke Nutrition Intervention Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harbin Medical University","startDate":"2025-03-23","conditions":"Ischemic Stroke","enrollment":190},{"nctId":"NCT06655376","phase":"PHASE4","title":"Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-10-02","conditions":"Bleeding, Clot Blood","enrollment":128},{"nctId":"NCT05825573","phase":"PHASE3","title":"Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-05-15","conditions":"Intracardiac Thrombus, STEMI, Heart Failure","enrollment":340},{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT07403942","phase":"NA","title":"The Skin Anti-Aging Effects of Vitamin K2 (MK-7): a Clinical Split-Face/Neck Trial","status":"COMPLETED","sponsor":"Nanjing Ascend Biotech Technology Co., Ltd.","startDate":"2024-12-26","conditions":"Skin Aging of Face and Neck","enrollment":36},{"nctId":"NCT07378514","phase":"","title":"Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices","status":"NOT_YET_RECRUITING","sponsor":"LumiraDx UK Limited","startDate":"2026-04","conditions":"Blood Clots, Infection and Inflammatory Reaction, Heart Disease","enrollment":30000},{"nctId":"NCT04752813","phase":"PHASE2","title":"A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)","status":"ACTIVE_NOT_RECRUITING","sponsor":"BPGbio","startDate":"2022-08-22","conditions":"Glioblastoma, Glioblastoma Multiforme","enrollment":50},{"nctId":"NCT06385275","phase":"PHASE1, PHASE2","title":"The Role of Vitamin K on Knee Osteoarthritis Outcomes","status":"RECRUITING","sponsor":"Boston University","startDate":"2025-06-03","conditions":"Osteo Arthritis Knee","enrollment":55},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07350538","phase":"NA","title":"The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Roehampton","startDate":"2025-12-10","conditions":"Healthy Subjects","enrollment":20},{"nctId":"NCT03968393","phase":"PHASE4","title":"Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-06-14","conditions":"Stroke, Atrial Fibrillation","enrollment":2270},{"nctId":"NCT03636295","phase":"PHASE3","title":"Low INR to Minimize Bleeding With Mechanical Valves Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-09-05","conditions":"Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement","enrollment":2625},{"nctId":"NCT05891119","phase":"EARLY_PHASE1","title":"Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Amgen","startDate":"2023-06-03","conditions":"Atopic Dermatitis","enrollment":21},{"nctId":"NCT07295327","phase":"NA","title":"Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia","status":"RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2025-09-30","conditions":"Hypercholesterolemia","enrollment":40},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT07256769","phase":"","title":"Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis","status":"RECRUITING","sponsor":"Regina Elena Cancer Institute","startDate":"2025-09-29","conditions":"Osteoporosis Secondary, Breast Cancer Females","enrollment":134},{"nctId":"NCT02614573","phase":"NA","title":"International Normalised Ratio Evaluation by Generalist Practitioners in Full-time Care Establishments for the Elderly","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2016-02","conditions":"Aged, Nursing Homes","enrollment":31},{"nctId":"NCT05943457","phase":"NA","title":"Vitamin K2 Supplementation in Adult Episodic Migraine","status":"RECRUITING","sponsor":"Sola Aoun Bahous, M.D. Ph.D.","startDate":"2024-03-06","conditions":"Migraine Headache, Arterial Stiffness, Vitamin K Deficiency","enrollment":160},{"nctId":"NCT07206537","phase":"NA","title":"The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Pediatrics Nephrology","enrollment":60},{"nctId":"NCT06081114","phase":"NA","title":"Micronutrient Dose Response Study in Bangladesh","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2023-10-22","conditions":"Micronutrient Status","enrollment":643},{"nctId":"NCT07199829","phase":"NA","title":"Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel","status":"RECRUITING","sponsor":"Madigan Army Medical Center","startDate":"2025-03-27","conditions":"Hypovitaminosis D, Hypovitaminosis","enrollment":96},{"nctId":"NCT04284839","phase":"PHASE3","title":"The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2021-07-18","conditions":"Bleeding Post Cardiac Surgery, Indication for Anticoagulation","enrollment":3500},{"nctId":"NCT06665919","phase":"NA","title":"The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models","status":"COMPLETED","sponsor":"Vistamedi Ltd.","startDate":"2023-06-15","conditions":"Coronary Artery Disease, Clopidogrel Resistance, Coronary Thrombosis","enrollment":283},{"nctId":"NCT03358706","phase":"PHASE1","title":"A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-02-02","conditions":"Crohn Disease, Ulcerative Colitis","enrollment":28},{"nctId":"NCT06573229","phase":"NA","title":"LIver FRAilty Management IN Cirrhosis (LIFRAMIN)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-08-02","conditions":"Sarcopenia, Cirrhosis, Liver, Malnutrition; Protein","enrollment":30},{"nctId":"NCT07048860","phase":"NA","title":"ICOPE INTENSE-K Pilot Study","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-07-09","conditions":"Ageing","enrollment":40},{"nctId":"NCT05081960","phase":"","title":"Evaluating the Vitamin K2 Status of Calcium-based Stone Formers","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2022-08-01","conditions":"Kidney Calculi, Calcium Oxalate Kidney Stones, Vitamin K 2","enrollment":60},{"nctId":"NCT05643651","phase":"PHASE4","title":"Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-06-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm","enrollment":100},{"nctId":"NCT05942053","phase":"PHASE4","title":"Role of Vitamin K2 in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-07-15","conditions":"Chronic Kidney Diseases","enrollment":44},{"nctId":"NCT07011095","phase":"EARLY_PHASE1","title":"DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2025-09-03","conditions":"Atrial Fibrillation (AF), Stroke (in Patients With Atrial Fibrillation)","enrollment":100},{"nctId":"NCT02318342","phase":"NA","title":"Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2014-12","conditions":"Prosthetic Valve Thrombosis","enrollment":3000},{"nctId":"NCT04286321","phase":"NA","title":"Achieving Nutritional Adequacy Of Vitamin K With An Egg/Plant-Based Food Pairing","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2021-06-01","conditions":"Nutritional Requirements","enrollment":10},{"nctId":"NCT03129490","phase":"PHASE4","title":"The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2023-04-01","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":11000},{"nctId":"NCT03129555","phase":"PHASE4","title":"The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2023-04-01","conditions":"Deep Vein Thrombosis, Pulmonary Embolism","enrollment":5000},{"nctId":"NCT05500443","phase":"NA","title":"The DANish COronary DEcalcification (DANCODE) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Odense University Hospital","startDate":"2023-02-08","conditions":"Coronary Artery Disease","enrollment":400},{"nctId":"NCT06867952","phase":"NA","title":"A Pilot Study of Vitamin K2 (Menaquinone-7, Soloways ™) in Patients With Osteopenia/Osteoporosis Carrying a VDR Gene Variant","status":"RECRUITING","sponsor":"S.LAB (SOLOWAYS)","startDate":"2024-05-03","conditions":"Osteoporosis, Osteopenia","enrollment":40},{"nctId":"NCT06875050","phase":"NA","title":"Antioxidant Supplements in Cystic Fibrosis Children","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-03-12","conditions":"Cystic Fibrosis (CF)","enrollment":60},{"nctId":"NCT06215430","phase":"PHASE1","title":"A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2021-01-11","conditions":"Healthy","enrollment":16},{"nctId":"NCT02798471","phase":"PHASE3","title":"Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2017-03-27","conditions":"Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT)","enrollment":290},{"nctId":"NCT01130025","phase":"PHASE3","title":"Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-08","conditions":"Venous Thromboembolism","enrollment":900},{"nctId":"NCT06402851","phase":"PHASE4","title":"Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)","status":"RECRUITING","sponsor":"Hospital Sirio-Libanes","startDate":"2024-12-18","conditions":"Atrium; Fibrillation, Chronic Kidney Diseases","enrollment":1500},{"nctId":"NCT03892824","phase":"NA","title":"Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Javelin Medical","startDate":"2019-04-15","conditions":"Atrial Fibrillation, Stroke","enrollment":100},{"nctId":"NCT04437654","phase":"PHASE4","title":"The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2020-07-28","conditions":"Atrial Fibrillation Patients With Intermediate Stroke Risk","enrollment":1800},{"nctId":"NCT06707909","phase":"PHASE4","title":"The Local Effect of Vitamin K2 on Bone Remodeling in Socket Preservation","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-02-15","conditions":"Socket Preservation","enrollment":20},{"nctId":"NCT05547750","phase":"NA","title":"Effect of Vitamin K2 in the Treatment of Nocturnal Leg Cramps in Older Population","status":"COMPLETED","sponsor":"The Third People's Hospital of Chengdu","startDate":"2022-10-01","conditions":"Nocturnal Leg Cramps","enrollment":200},{"nctId":"NCT04062097","phase":"","title":"Registration of Idarucizumab for Patients with IntraCranial Hemorrhage","status":"COMPLETED","sponsor":"University Hospital, Essen","startDate":"2019-09-19","conditions":"Intracranial Hemorrhage","enrollment":104},{"nctId":"NCT06606275","phase":"","title":"The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on Dialysis","status":"COMPLETED","sponsor":"Abu Dhabi Health Services Company","startDate":"2024-01-01","conditions":"End-Stage Kidney Disease (ESKD), Non-valvular Atrial Fibrillation (NVAF), Venous Thromboembolism (VTE)","enrollment":67},{"nctId":"NCT02464969","phase":"PHASE4","title":"Apixaban for the Acute Treatment of Venous Thromboembolism in Children","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2015-11-22","conditions":"Venous Thromboembolism","enrollment":229},{"nctId":"NCT05925309","phase":"NA","title":"Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-07-01","conditions":"Biliary Atresia, Cholangitis, Anti-Bacterial Agents","enrollment":356},{"nctId":"NCT05873933","phase":"NA","title":"An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes","status":"WITHDRAWN","sponsor":"Hemptress","startDate":"2024-07-01","conditions":"Acne, Eczema, Skin Aging","enrollment":""},{"nctId":"NCT05356936","phase":"NA","title":"Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2022-06-01","conditions":"Post-acute COVID-19 Syndrome","enrollment":151},{"nctId":"NCT06615596","phase":"EARLY_PHASE1","title":"Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-01","conditions":"Atrial Fibrillation (AF)","enrollment":3160},{"nctId":"NCT05285787","phase":"PHASE2","title":"A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)","status":"COMPLETED","sponsor":"Epizon Pharma, Inc.","startDate":"2019-03-01","conditions":"End-Stage Renal Disease (ESRD)","enrollment":18},{"nctId":"NCT04780061","phase":"PHASE3","title":"Dietary Supplements for COVID-19","status":"TERMINATED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2021-07-12","conditions":"Covid19","enrollment":90},{"nctId":"NCT02886962","phase":"PHASE4","title":"Oral Anticoagulation in Haemodialysis Patients","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2017-07-12","conditions":"Kidney Failure, Chronic","enrollment":50},{"nctId":"NCT04246762","phase":"PHASE1","title":"Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4","status":"COMPLETED","sponsor":"R-Pharm International, LLC","startDate":"2021-11-16","conditions":"Rheumatoid Arthritis","enrollment":17},{"nctId":"NCT04249401","phase":"","title":"Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)","status":"COMPLETED","sponsor":"Bayer","startDate":"2020-03-01","conditions":"Atrial Fibrillation","enrollment":134897},{"nctId":"NCT02735902","phase":"PHASE4","title":"Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1)","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2017-06-01","conditions":"Transcatheter Aortic Valve Replacement","enrollment":170},{"nctId":"NCT04254783","phase":"PHASE1","title":"A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease","status":"COMPLETED","sponsor":"AbbVie","startDate":"2020-05-27","conditions":"Ulcerative Colitis (UC), Crohn's Disease","enrollment":20},{"nctId":"NCT04437303","phase":"PHASE4","title":"Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2020-11-25","conditions":"Aortic Valve Disease, Aortic Valve Stenosis, Stroke","enrollment":858},{"nctId":"NCT02046460","phase":"PHASE3","title":"Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD","status":"COMPLETED","sponsor":"Stefan Engelter","startDate":"2013-09","conditions":"Cervical Artery Dissection","enrollment":194},{"nctId":"NCT05995522","phase":"NA","title":"Effect of Vitamin K2 Over Osteocalcin, Leptin, Cytokines, and Cardiovascular Risk in Young Adults With Overweight and Obesity","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2023-09-01","conditions":"Overweight and Obesity, Cardiometabolic Risk Factors","enrollment":51},{"nctId":"NCT01556659","phase":"NA","title":"LV Thrombus After Acute AMI: A Randomized Controlled Trial","status":"TERMINATED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2012-03","conditions":"Ventricular Thrombosis Mural Following Myocardial Infarction","enrollment":25},{"nctId":"NCT04066764","phase":"PHASE3","title":"Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-08","conditions":"Venous Thromboembolism","enrollment":200},{"nctId":"NCT05006287","phase":"PHASE2","title":"The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Paul's Hospital, Canada","startDate":"2022-10-12","conditions":"Atrial Fibrillation","enrollment":100},{"nctId":"NCT05205863","phase":"PHASE1, PHASE2","title":"Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation","status":"COMPLETED","sponsor":"Prothya Biosolutions","startDate":"2021-11-12","conditions":"Healthy Volunteers","enrollment":69},{"nctId":"NCT06018740","phase":"NA","title":"A Study to Examine the Effects of a Daily Supplement on Common Symptoms of Perimenopause and Menopause","status":"COMPLETED","sponsor":"Hologram Sciences","startDate":"2023-08-14","conditions":"Menopause, Perimenopause","enrollment":40},{"nctId":"NCT03645564","phase":"NA","title":"Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department","status":"TERMINATED","sponsor":"University Hospital, Bordeaux","startDate":"2018-10-16","conditions":"Atrial Fibrillation","enrollment":221},{"nctId":"NCT03718884","phase":"PHASE1","title":"A Study of Mirikizumab in Participants With Plaque Psoriasis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-10-23","conditions":"Psoriasis","enrollment":29},{"nctId":"NCT06187311","phase":"PHASE4","title":"Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation","status":"RECRUITING","sponsor":"Korea University Anam Hospital","startDate":"2023-01-12","conditions":"Atrial Fibrillation, Anticoagulant Adverse Reaction","enrollment":940},{"nctId":"NCT04450212","phase":"NA","title":"Vitamin K Supplementation Study in Healthy Volunteers (Aim 2B)","status":"TERMINATED","sponsor":"University of Washington","startDate":"2017-08-25","conditions":"Vitamin K Status","enrollment":106},{"nctId":"NCT04676958","phase":"NA","title":"viTAmin K2 and rEcOVery From ExeRcise","status":"COMPLETED","sponsor":"University of Glasgow","startDate":"2021-04-01","conditions":"Inflammation, Oxidative Stress, Vitamin K","enrollment":80},{"nctId":"NCT06144866","phase":"","title":"Evaluataion of NOAC Levels in Acute Stroke","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2020-05-01","conditions":"Ischemic Stroke, Anticoagulant Adverse Reaction","enrollment":1000},{"nctId":"NCT02864758","phase":"","title":"Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-09-08","conditions":"Atrial Fibrillation","enrollment":99999},{"nctId":"NCT03702582","phase":"PHASE3","title":"Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-04-30","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":100},{"nctId":"NCT05022758","phase":"","title":"A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-10-06","conditions":"Non-valvular Atrial Fibrillation (NVAF)","enrollment":45000},{"nctId":"NCT04730037","phase":"PHASE3","title":"Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)","status":"COMPLETED","sponsor":"Kyushu University","startDate":"2021-03-23","conditions":"CTEPH","enrollment":74},{"nctId":"NCT04010578","phase":"NA","title":"Effects of VitamIN K2 and D3 supplementaTion on PET/MRI in Carotid Artery Disease","status":"UNKNOWN","sponsor":"Academisch Ziekenhuis Maastricht","startDate":"2024-01-01","conditions":"Coronary Artery Disease, Carotid Artery Disease","enrollment":52},{"nctId":"NCT03064035","phase":"PHASE4","title":"Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2017-04-05","conditions":"Acute Bleeding on Long-Term Anticoagulation Therapy, Hemorrhage, Significant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)","enrollment":79},{"nctId":"NCT00839163","phase":"PHASE2","title":"Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03","conditions":"Venous Thrombosis, Deep Vein Thrombosis","enrollment":613},{"nctId":"NCT04718740","phase":"PHASE1","title":"A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-06-25","conditions":"Recurrent Ovarian Cancer","enrollment":33},{"nctId":"NCT05022563","phase":"","title":"Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-08-31","conditions":"Venous Thromboembolism","enrollment":55759},{"nctId":"NCT05375630","phase":"NA","title":"Vitamin K2 and Muscle Weakness in Type 2 Diabetes","status":"UNKNOWN","sponsor":"Dasman Diabetes Institute","startDate":"2022-03-21","conditions":"Diabete Type 2","enrollment":150},{"nctId":"NCT04981041","phase":"PHASE4","title":"Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI","status":"UNKNOWN","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2021-12-16","conditions":"Acute Coronary Syndrome, Atrial Fibrillation","enrollment":2334},{"nctId":"NCT05675163","phase":"NA","title":"Antioxidant and Immune Effects of Vitamin K2","status":"COMPLETED","sponsor":"NIZO Food Research","startDate":"2022-11-15","conditions":"Oxidative Stress, Inflammation","enrollment":60},{"nctId":"NCT02740712","phase":"PHASE1","title":"Pharmacokinetic Drug-Drug Interaction Study of Rucaparib","status":"COMPLETED","sponsor":"pharmaand GmbH","startDate":"2016-04","conditions":"Neoplasms","enrollment":17},{"nctId":"NCT05592509","phase":"NA","title":"Antioxidant Effect of Ozonated Vegetable Oil and Vitamins in Moderately Active Subjects","status":"COMPLETED","sponsor":"S&R Farmaceutici spa","startDate":"2022-09-15","conditions":"Oxidative Stress, Inflammation","enrollment":20},{"nctId":"NCT05037162","phase":"PHASE2","title":"Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19","status":"COMPLETED","sponsor":"MGC Pharmaceuticals d.o.o","startDate":"2022-10-11","conditions":"Covid19, Corona Virus Infection","enrollment":240},{"nctId":"NCT04002011","phase":"PHASE2","title":"DOAC Versus VKA After Cardiac Surgery","status":"WITHDRAWN","sponsor":"Laval University","startDate":"2022-03-09","conditions":"Anticoagulant-induced Bleeding","enrollment":""},{"nctId":"NCT05750602","phase":"NA","title":"Combined Effect of LIMICOL and Physical Activity on LDL Cholesterol and Muscle Function.","status":"COMPLETED","sponsor":"Lescuyer Laboratory","startDate":"2013-11","conditions":"Hypercholesterolemia","enrollment":40},{"nctId":"NCT04569279","phase":"PHASE3","title":"Rivaroxaban vs. Warfarin in CVT Treatment","status":"COMPLETED","sponsor":"Damascus University","startDate":"2017-09-01","conditions":"Cerebral Vein Thrombosis","enrollment":71},{"nctId":"NCT05713045","phase":"","title":"Late Vitamin K Deficiency-related Bleeding in Neonates (VKLB): Comparison of Different Strategies to Prophylaxis","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2020-03-27","conditions":"Late Vitamin K Deficiency-related Bleeding","enrollment":80},{"nctId":"NCT04285450","phase":"NA","title":"The Clinical Effect of Vitamin K Administration in Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-10-27","conditions":"Diabetes Mellitus, Type 2","enrollment":106},{"nctId":"NCT05689632","phase":"NA","title":"Vitamins D and K Effects on Vascular Function in Obese Adults.","status":"UNKNOWN","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2022-07-15","conditions":"Obesity, Vitamin D3 Deficiency","enrollment":100},{"nctId":"NCT02870829","phase":"PHASE2","title":"Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K","status":"COMPLETED","sponsor":"National University Health System, Singapore","startDate":"2016-07","conditions":"Vascular Calcification, Systemic and Arterial Stiffness, Complication of Hemodialysis","enrollment":178}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":429,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["PLACEBO GROUP","menaquinone-7"],"phase":"marketed","status":"active","brandName":"Vitamin K 2","genericName":"Vitamin K 2","companyName":"Catholic University of Salta","companyId":"catholic-university-of-salta","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vitamin K2 is a small molecule that has been studied as a potential treatment for various conditions related to calcification of heart valves, including aortic valve stenosis and mitral valve calcification. It works through the carboxylation mechanism of matrix Gla protein (MGP), which is involved in inhibiting calcification.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}